AMI MultiStem®, bone marrow-derived cells for acute myocardial infarction
MultiStem® are adult bone marrow-derived cells used for the treatment of acute myocardial infarction and congestive heart failure. A Phase I study assessing the efficacy and safety of MultiStem® in the treatment of acute myocardial infarction demonstrated that it was well tolerated at all tested dose levels and led to improved heart function in treated patients, as measured by the mean left ventricular ejection fraction.
Read More
Product Information for
AMI MultiStem®, bone marrow-derived cells for acute myocardial infarction
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access